Silexion Therapeutics extraordinary meeting again lacks quorum, proceeds under articles of association

Silexion Therapeutics held an extraordinary general meeting on Sept. 23, 2026; shareholders rejected a proposal to add 175 million authorized ordinary shares and a 1-for-15 reverse share split.